Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Disease on Intensive Care Units (ICU)
NCT ID: NCT01169168
Last Updated: 2010-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
250 participants
OBSERVATIONAL
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. chronicle liver diseases
* primary biliary cirrhosis
* primary sclerosing cholangitis
* alcoholic liver cirrhosis
* hepatitis b or C
* Wilson's disease
* cryptogenic cirrhosis
2. Septic Inflammatory Response Syndrome (SIRS)
* sepsis
* septic shock
3. patients after lysis
should be included
Blood samples will be gathered from the patients to measure fibrinogen with 5 different methods.
The methods are:
* Clauss fibrinogen
* PT-Derived fibrinogen
* immunoturbidimetric method
* heat-precipitated fibrinogen
* Schulz fibrinogen
The result of these tests will be correlated with laboratory values which are gathered in routine and the clinical outcomes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Characterization and Pathogenesis of ACLF
NCT04975490
Identification of Liver Fibrosis Biomarkers
NCT06819917
Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver Disease
NCT02658786
Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease
NCT07051863
Examination the Ability to Early Diagnose HCC by Combining Three Biomarkers Technology Developed by WAKO, And Their Relevance to Cirrhotic of Patients With Various Backgrounds and the Israeli Population.
NCT02826005
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* sepsis
* septic shock
* chronicle liver disease (MELD-Score \>10)
* patient after lysis
* patient agrees
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johann Wolfgang Goethe University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Johann Wolfgang Goethe University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johann Wolfgang Goethe University Hospital
Frankfurt am Main, Hesse, Germany
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FibICU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.